A tablet that dissolves under the tongue could replace expensive auto-injectors.
EpiPens have been used for decades as a way to give epinephrine and treat anaphylaxis. However, Palforzia is the only FDA-approved product in the world that provides a unique set of treatment plans to weaken severe allergic reactions due to a peanut allergy.
Why is everyone talking about an injector?
The research suggests a need for more education, showing caregivers “how to use the autoinjectors and walking them through what signs to look for,” said Melissa Robinson, an allergist and lead author of the study, published in Annals of Allergy, Asthma and Immunology in July.
Thirteen year-old Natalie Giorgi probably didn't know the name of the company that makes EpiPen. But the Sacramento, Calif., girl's death from a peanut-induced allergy attack in 2013 inspired passage of the California law that made the Mylan product a staple at every school in the state.
The EpiPen was invented in the 1970s by a biomedical engineer, Sheldon Kaplan, who was searching for a way to treat allergic reactions quickly.
What he came up with was the EpiPen we know today: a pen-like device that delivers a premeasured dose of the hormone epinephrine in emergency situations. The device is ubiquitous in our country, carried by those with asthma or life-threatening allergies.
The bottom line is that no parent should have to send their child off to school or camp, hoping and praying for their child’s basic safety, because they cannot afford to purchase essential medication.
After a price-gouging scandal, the pharmaceutical company will release a cheaper, generic version of its life-saving medical product.
Aphorisms like “the pot calling the kettle black” persist because they keep being proven relevant. Such is the case with politicians’ outrage over Mylan Pharmaceuticals’ price gouging for its life-saving EpiPen: their price has risen from less than $100 for a two-pack in 2007 to $600 today.
The government (“pot”) is loudly and very publicly calling Mylan (“the kettle”) “black”—at fault—for something the government itself did.
I tell these stories not as a victim, but to show what a profound impact the EpiPen has had, allowing me to live my life. I have never felt that having these allergies inhibits me.
Adrenaclick, a generic version of an epinephrine self-injector, is a lower-cost option. Here's how to get it.
You can, but here’s a spoiler alert: a medical ethicist says you shouldn’t.
Except that consumers will have to know enough to ask for it. And that’s not how medicine should work.
Economics can work against you or for you. If policy makers and patients join together, they can increase the competition in the drug market and hold prices down while still maintaining patient safety. No need to reinvent the wheel, just remember the lessons of economics.
Politicians and federal regulators allege pharmaceutical maker Mylan cheated taxpayers out of millions of dollars after raising the price of the lifesaving allergy injectors.
EpiPens are a perfect example of a health care nightmare. They’re also just a typical example of the dysfunction of the American health care system.
In fact, with EpiPens, experts think the expiration date is a pretty good gauge of the injectable drug’s potency. Because epinephrine doesn’t maintain its chemical integrity and can’t remain potent for very long, those dates are among the shortest in the drug industry, at about 18 months.
Boston mom Denise Clark has been buying EpiPens annually for the past 16 years, ever since her son was diagnosed with a serious peanut allergy. Problem is, he won’t carry his EpiPen around with him — because it won’t fit into his pocket.
“It’s large and it’s impractical,” Clark said. “Where’s he going to put it?”
This underscores a simple truth: EpiPens just aren’t that great.